Novelix Pharmaceuticals Annual General Meeting
Novelix Pharmaceuticals held its 32nd Annual General Meeting on 30th September, 2026, transacting ordinary and special business items via e-voting and video conferencing.
ALFA Filings
Every announcement, straight from the exchange
Every Novelix Pharmaceuticals annual general meeting announcement on NSE and BSE, newest first, each with its own page.
Time
5 announcements
Novelix Pharmaceuticals held its 32nd Annual General Meeting on 30th September, 2026, transacting ordinary and special business items via e-voting and video conferencing.
Novelix Pharmaceuticals Limited will hold its 32nd Annual General Meeting on September 30, 2026. The company has fixed September 23, 2026, as the cut-off date for e-voting.
Novelix Pharmaceuticals held an Extra Ordinary General Meeting on July 1, 2026. The meeting included a special resolution for issuing equity shares on preferential basis.
Novelix Pharmaceuticals convened an EGM for July 1, 2026, to approve a ₹6.84 Crore preferential allotment. The capital raise targets non-promoter investors to fund technology transfers.
Novelix Pharmaceuticals has scheduled an EGM for July 01, 2026, via video conferencing. The board fixed June 24, 2026, as the cut-off date for shareholder e-voting eligibility.